Printer Friendly
The Free Library
19,588,385 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CCM Research Issues Update Report on Starpharma Holdings.


TORONTO -- CCM CCM Contemporary Christian Music
CCM Critical Care Medicine
CCM County College of Morris (New Jersey)
CCM Chama Cha Mapinduzi (political party, Tanzania)
CCM CORBA Component Model
 Research analyst, Mohammad Sharifzadeh, PhD, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , has written an update report on Starpharma Holdings.

Starpharma Holdings, Ltd. (SPHRY: OTCQX) is an Australian-based company engaged in the development and application of dendrimer den·dri·mer  
n.
A polymer in which the atoms are arranged in many branches and subbranches along a central backbone of carbon atoms. Also called cascade molecule.
 nanotechnologies as drugs and in other life science applications. Starpharma's business strategy is to use dendrimer-based nanotechnology to discover, develop and commercialize pharmaceuticals for serious human diseases and in life sciences.

In the report the analyst states that "SPHRY's lead dendrimer product, VivaGel[TM], addresses markets with huge potentials and stands at the forefront of global HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome  prevention strategies."

The analyst continues to state that "Starpharma has a healthy balance sheet. They have a strong cash position which can support their operating and R&D expenses should there be a shortfall in revenues. Starpharma has almost a debt free balance sheet with substantial equity which provides the company with the opportunity of external financing In the theory of capital structure, External financing is the phrase used to describe funds that firms obtain from outside of the firm. It is contrasted to internal financing which consists mainly of profits retained by the firm for investment.  should the need arises." A free copy of the report can be found at www.ccmopportunitybase.com.

CCM Research subscribes to the "Standards for Independent Research Providers" and the principles contained in the Analyst/Corporate Issuer Guidelines jointly promulgated prom·ul·gate  
tr.v. prom·ul·gat·ed, prom·ul·gat·ing, prom·ul·gates
1. To make known (a decree, for example) by public declaration; announce officially. See Synonyms at announce.

2.
 by the CFA Institute and the National Investor Relations Institute The National Investor Relations Institute, known as "NIRI", is the professional association for investor relations professionals in the United States.

NIRI was founded in 1969 and has more than 4,500 members, both from the United States and other countries.
, described at: http://www.cfainstitute.org and http://www.niri.org.

CCM Research, is a division of Cronus Capital Markets, Inc. Cronus Capital Markets, Inc., through its CCM Consulting division, entered into a one year $30,000.00 contract with the Company to assist it with the creation and execution of information-based strategies to overcome market inefficiencies that are commonplace for the vast majority of public companies; such as share illiquidity and stagnant market presence.

Cronus Capital Markets (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. CCM's equity indexes receive international attention and represent important new benchmarks of growth.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 31, 2007
Words:313
Previous Article:Full House Resorts Announces Favorable Court Ruling.
Next Article:Azaya Therapeutics, Inc. Elects Ze'ev Shaked, Ph.D., to Board of Directors.
Topics:



Related Articles
A 'beta' approach to learning.
Applying Continuous Controls Monitoring for achieving compliance and business improvement: Continuous Controls Monitoring has emerged as a solution...
NIH FUNDS CLINICAL DEVELOPMENT OF VIVAGEL FOR GENITAL HERPES.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles